(Q47899867)

6 February 2018

review article

1 reference

title

Inflammatory bowel disease: etiology and pathogenesis. (English)

1 reference

6 February 2018

inflammatory bowel diseases

main subject

0 references

author name string

Fiocchi C

series ordinal

1

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

6 February 2018

published in

Gastroenterology

1 reference

6 February 2018

volume

115

1 reference

6 February 2018

page(s)

182-205

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

Lack of association between smoking and inflammatory bowel disease in Jewish patients in Israel

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Transdermal nicotine for active ulcerative colitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Nicotine inhibits the in vitro production of interleukin 2 and tumour necrosis factor-alpha by human mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

The influence of zinc status and malnutrition on immunological function in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Elemental diet as primary treatment of acute Crohn's disease: a controlled trial

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

7 January 2021

Ten years' experience with an elemental diet in the management of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Intestinal permeability and the prediction of relapse in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Is small intestinal permeability really increased in relatives of patients with Crohn's disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Composition of human colonic mucin. Selective alteration in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Ion exchange chromatography of purified colonic mucus glycoproteins in inflammatory bowel disease: absence of a selective subclass defect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Colonic glycoproteins in monozygotic twins with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Familial occurrence of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

High prevalence of antibodies to intestinal epithelial antigens in patients with inflammatory bowel disease and their relatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Histocompatibility antigens in patients with inflammatory-bowel disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Genetic markers may predict disease behavior in patients with ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Distinct associations of HLA class II genes with inflammatory bowel disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

HLA-linked susceptibility and resistance genes in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Association of HLA class II genes with susceptibility to Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3*0301 allele

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Mapping of a susceptibility locus for Crohn's disease on chromosome 16

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Preliminary evidence for genetic anticipation in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Inflammatory products of commensal bacteria and gastro-intestinal disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Pouchitis: result of microbial imbalance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Effects of intestinal stasis on intercellular adhesion molecule 1 expression in the rat: role of enteric bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Possible role of mycobacteria in inflammatory bowel disease. II. Mycobacterial antibodies in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Serum antibodies to mycobacterial antigens in active Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Crohn's disease and the mycobacterioses: a review and comparison of two disease entities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Mycobacterium paratuberculosis DNA in Crohn's disease tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Agent transmissible from Crohn's disease tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Granulomatous vasculitis in crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Evidence of persistent measles virus infection in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Perinatal measles infection and subsequent Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Is measles vaccination a risk factor for inflammatory bowel disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Inherited disorders of coagulation appear to protect against inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Mucosal subclass distribution of immunoglobulin G-producing cells is different in ulcerative colitis and Crohn's disease of the colon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Autoantibodies in human ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Circulating immune complexes in ulcerative colitis and Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

A Study of the Immunologic Aspects of Chronic Ulcerative Colitis and Transmural Colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Sensitization to epithelial antigens in chronic mucosal inflammatory disease. Characterization of human intestinal mucosa-derived mononuclear cells reactive with purified epithelial cell-associated components in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Low Prevalence of p-ANCA in Unaffected Relatives of Patients with Ulcerative Colitis from a Mediterranean Area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Antibodies to neutrophil cytoplasm in Italian patients with ulcerative colitis: sensitivity, specificity and recognition of putative antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

In vitro studies of ulcerative colitis. II. Cytotoxic action of white blood cells from patients on human fetal colon cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Scanning electron-microscopic lesions in Crohn's disease: relevance for the interpretation of postoperative recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Increased numbers of macrophages in noninflamed gastroduodenal mucosa of patients with Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Phenotypic analysis of lamina propria lymphocytes. Predominance of helper-inducer and cytolytic T-cell phenotypes and deficiency of suppressor-inducer phenotypes in Crohn's disease and control patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Immune activation genes in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Studies on isolated gut mucosal lymphocytes in inflammatory bowel disease. Detection of activated T cells and enhanced proliferation to Staphylococcus aureus and lipopolysaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Immunoregulatory function of human intestinal mucosa lymphoid cells: evidence for enhanced suppressor cell activity in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Evidence for the effects of a superantigen in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Crohn's disease (CD) patients suffering from peripheral arthritis or ankylosing spondylitis reveal restricted T cell receptor V beta regions in different temporal phases of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Immunohistochemical characterization, distribution, and ultrastructure of lymphocytes bearing T-cell receptor γ/δ in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Polyclonal nature of the intestinal mucosal lymphocyte populations in inflammatory bowel disease. A molecular genetic evaluation of the immunoglobulin and T-cell antigen receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

T cell antigen receptor V gene usage. Increases in V beta 8+ T cells in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

T cell receptor V beta expression by mucosal T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

T cell receptor vβ gene expression in inflammatory bowel disease lamina propria lymphocytes: evidence for altered vβ gene usage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Selective expansion of specific T cell receptors in the inflamed colon of Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Immunohistological characterization of intraepithelial and lamina propria lymphocytes in control ileum and colon and in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Phenotypic characterization of isolated intraepithelial lymphocytes in patients with ulcerative colitis and normal controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Expression of adhesion molecules and HLA-DR by macrophages and dendritic cells in aphthoid lesions of Crohn's disease: an immunocytochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Neutrophil dysfunction in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

The jejunal secretion of histamine is increased in active Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Crohn's disease: transmission electron microscopic studies. III. Target tissues. Proliferation of and injury to smooth muscle and the autonomic nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Evidence for function of Ia molecules on gut epithelial cells in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Human intestinal epithelial cells express functional cytokine receptors sharing the common gamma c chain of the interleukin 2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Infection of human intestinal epithelial cells with invasive bacteria upregulates apical intercellular adhesion molecule-1 (ICAM)-1) expression and neutrophil adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Lack of induction of suppressor T cells by intestinal epithelial cells from patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Collagen synthesis by human intestinal smooth muscle cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

The stress response and the regulation of inflammatory disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Differential expression of substance P receptors in patients with Crohn's disease and ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Topical treatment of ulcerative proctitis with lidocaine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Isolation and longterm culture of human intestinal microvascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Fibroblasts and other structural cells in airway inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Remission of Crohn's disease after human immunodeficiency virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Interferon gamma production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Interleukin 4 in inflammatory bowel disease and mucosal immune reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Inflammatory bowel disease mucosal biopsies have specialized lymphokine mRNA profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Tumour necrosis factor alpha in stool as a marker of intestinal inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Tumor necrosis factor-alpha is not elevated in children with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Neutrophil-activating peptide (interleukin-8) in colonic mucosa from patients with Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Interleukin 8: cells of origin in inflammatory bowel disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Increased expression of keratinocyte growth factor messenger RNA associated with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Eicosanoids and the gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Role of reactive oxygen metabolites in experimental colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Potential role of nitric oxide in a model of chronic colitis in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Nitric oxide synthase activity in ulcerative colitis and Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Depleted mucosal antioxidant defences in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

The colonic epithelium in ulcerative colitis: an energy-deficiency disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Treatment of diversion colitis with short-chain-fatty acid irrigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Rectal irrigation with short-chain fatty acids for distal ulcerative colitis. Preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Aberrant binding of lamina propria lymphocytes to vascular endothelium in inflammatory bowel diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Light and electron microscopic immunolocalization of endothelial leucocyte adhesion molecule-1 in inflammatory bowel disease. Morphological evidence of active synthesis and secretion into vascular lumen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Expression of vascular adhesion molecules in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Circulating soluble intercellular adhesion molecule-1 (sICAM-1) in active inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin alpha 4 beta 7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Experimental models of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Effect of immunologic reactions on rat intestinal epithelium. Correlation of increased permeability to chromium 51-labeled ethylenediaminetetraacetic acid and ovalbumin during acute inflammation and anaphylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Severe colitis in mice with aberrant thymic selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Appendectomy protects against ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Characterization of spontaneous colitis in cotton-top tamarins (Saguinus oedipus) and its response to sulfasalazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Temperature-metabolism relations in the cotton-top tamarin (Saguinus oedipus) model for ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Antibodies to interleukin 12 abrogate established experimental colitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Biologic therapy for inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Antibiotic use in Crohn's disease: why and how?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

Non-smoking: a feature of ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

7 January 2021

Smoking and Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

7 January 2021

Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European Cooperative Crohn's Disease Study. IV.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

7 January 2021

Immunohistochemical examination for mycobacteria in intestinal tissues from patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

7 January 2021

Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970381-6

7 January 2021

10.1016/S0016-5085(98)70381-6

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

9649475

1 reference

6 February 2018